DAIDONE, VIVIANA
 Distribuzione geografica
Continente #
NA - Nord America 2.879
EU - Europa 322
AS - Asia 168
OC - Oceania 2
SA - Sud America 2
AF - Africa 1
Totale 3.374
Nazione #
US - Stati Uniti d'America 2.877
CN - Cina 127
IT - Italia 101
SE - Svezia 65
FI - Finlandia 48
VN - Vietnam 35
GB - Regno Unito 33
DE - Germania 27
UA - Ucraina 23
NL - Olanda 8
BE - Belgio 5
IE - Irlanda 5
IN - India 4
CH - Svizzera 3
CA - Canada 2
EC - Ecuador 2
NZ - Nuova Zelanda 2
AT - Austria 1
BG - Bulgaria 1
DK - Danimarca 1
FR - Francia 1
IR - Iran 1
JP - Giappone 1
NG - Nigeria 1
Totale 3.374
Città #
Fairfield 507
Woodbridge 322
Chandler 287
Ashburn 229
Houston 222
Ann Arbor 207
Seattle 183
Wilmington 183
Cambridge 166
Jacksonville 90
Princeton 55
San Diego 50
Padova 47
Beijing 43
Dong Ket 35
Des Moines 27
Roxbury 27
Medford 26
Nanjing 19
Helsinki 18
Boardman 16
New York 15
London 9
Hebei 7
Nanchang 7
Shenyang 7
Cagliari 6
Washington 6
Dublin 5
Jiaxing 5
Las Vegas 5
Fuzhou 4
Hefei 4
Redwood City 4
Trieste 4
Waanrode 4
Borås 3
Changsha 3
Indiana 3
Kharkiv 3
Kunming 3
Milan 3
Norwalk 3
Auburn Hills 2
Carmignano Di Brenta 2
Falls Church 2
Guangzhou 2
Guardiagrele 2
Hounslow 2
Kilburn 2
Mediglia 2
Ningbo 2
Parma 2
Phoenix 2
Quito 2
Rockville 2
Southwark 2
Tianjin 2
Asir 1
Brendola 1
Brussels 1
Charlotte 1
Chiswick 1
Chongqing 1
Christchurch 1
Enschede 1
Ferentino 1
Geneva 1
Haikou 1
Hangzhou 1
Ichibacho 1
Jinan 1
Kiev 1
Lagos 1
Los Angeles 1
Lugano 1
Lyngby 1
Moggio Udinese 1
Munich 1
Ogden 1
Pinehaven 1
Portici 1
San Jose 1
Sapri 1
Sofia 1
Zhengzhou 1
Ürümqi 1
Totale 2.931
Nome #
Diagnosis and complications of Cushing's disease: gender-related differences. 147
Diagnostic Value of Measuring Platelet Von Willebrand Factor in Von Willebrand Disease. 142
A venous thromboembolism risk assessment model for patients with Cushing’s syndrome 123
Type 2B von Willebrand disease with or without large multimers: A distinction of the two sides of the disorder is long overdue 121
Haemostatic patterns and bleeding scores of a genetically characterised Italian family with combined haemophilia A and type 1 von Willebrand disease 120
New insight into the Hypercoagulability of Cushing's Syndrome 117
Usefulness of the Total Thrombus-Formation Analysis System (T-TAS) in the diagnosis and characterization of von Willebrand disease 114
Loss of cysteine 584 impairs the storage and release, but not the synthesis of von Willebrand factor 111
Spontaneous hemarthrosis in combined Glanzmann thrombasthenia and type 2N von Willebrand disease. 110
The p.R1819_C1948delinsS mutation makes von Willebrand factor ADAMTS13-resistant and reduces its collagen-binding capacity 107
von Willebrand factor propeptide makes it easy to identify the shorter von Willebrand factor survival in patients with type 1 and type Vicenza von Willebrand disease. 104
Severe, recessive type 1 is a discrete form of von Willebrand disease: The lesson learned from the c.1534-3C>A von Willebrand factor mutation 101
von Willebrand factor abnormalities in aortic valve stenosis:pathophysiology and impact on bleeding. 97
Cryptic noncanonical splice site activation is part of the mechanism that abolishes multimer organization in the c.2269_2270del von Willebrand factor 92
Higher and lower active circulating VWF levels: different facets of von Willebrand disease 90
Type 1 von Willebrand disease due to reduced von Willebrand factor synthesis and/or survival: observations from a case series. 90
Hypercortisolism and pregnancy upregulate von Willebrand factor through different mechanisms: report on a pregnant patient with Cushing's syndrome. 89
The elusive and heterogeneous pattern of type 2M von Willebrand disease: A diagnostic challenge 88
A novel von Willebrand factor mutation (11372S) associated with type 2B-like von Willebrand disease: An elusive phenotype and a difficult diagnosis 85
Reduced survival of type 2B von Willebrand factor, irrespective of large multimer representation or thrombocytopenia. 83
C2362F mutation gives rise to an ADAMTS13-resistant von Willebrand factor 82
Venous thromboembolism in patients with Cushing's syndrome: need of a careful investigation of the prothrombotic risk profile. 82
A Mechanistic Model to Quantify von Willebrand Factor Release, Survival and Proteolysis in Patients with von Willebrand Disease 79
Coagulopathy in Cushing's syndrome. 76
Type 2N von Willebrand disease: Characterization and diagnostic difficulties 76
Microsatellite (GT)(n) is part of the von Willebrand factor (VWF) promoter region that influences the glucocorticoid-induced increase in VWF in Cushing's syndrome. 75
A common ancestor more than 10,000 years old for patients with R854Q-related type 2N von Willebrand's disease in Italy. 74
Type 3 von Willebrand disease mistaken for moderate haemophilia A: a lesson still to be learned 74
Multiple von Willebrand factor mutations in patients with recessive type 1 von Willebrand disease. 74
Acquired von Willebrand Syndrome Hiding Inherited von Willebrand Disease Can Explain Severe Bleeding in Patients With Aortic Stenosis. 71
Type 1 von Willebrand disease due to a vicinal cysteine loss (p.C524Y) disclosed after a thrombotic episode 69
Microsatellite (GT)(n) repeats and SNPs in the von Willebrand factor gene promoter do not influence circulating von Willebrand factor levels under normal conditions. 65
Two novel ITGA2B mutations in a Glanzmann thrombasthaenia family associated with different platelet phenotypic expression 65
Haplotypes of Von Willebrand factor promoter predict thrombotic risk in Cushing's syndrome 59
A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor 58
The Bleeding Assessment Tool and laboratory data in the characterisation of a female with inherited haemophilia A 49
An apparent silent nucleotide substitution (c.7056C>T) in the von Willebrand factor gene is responsible for type 1 von Willebrand disease. 45
I polimorfismi del gene del fattore Von Willebrand (VWF) modulano l'aumento del VWF, indotto da corticosteroidi, nella sindrome di Cushing 45
null 28
Von Willebrand disease type Vicenza: In search of a classification for the archetype of reduced von Willebrand factor survival 16
The lesson learned from the new c.2547-1G>T mutation combined with p.R854Q:when a type 2N mutation reveals a quantitative von Willebrand factor defect. 16
Assessment of von Willebrand factor propeptide improves the diagnosis of von Willebrand disease. 15
The Lesson Learned from the New c.2547-1G>T Mutation Combined with p.R854Q: When a Type 2N Mutation Reveals a Quantitative von Willebrand Factor Defect 3
Totale 3.427
Categoria #
all - tutte 11.158
article - articoli 10.703
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.861


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019305 0 0 0 0 0 0 0 0 0 65 126 114
2019/2020694 92 22 15 43 82 54 71 92 80 63 54 26
2020/2021618 28 23 18 49 27 58 47 40 103 89 58 78
2021/2022648 18 46 98 63 47 45 28 81 24 8 59 131
2022/2023502 92 75 3 73 71 66 4 34 54 3 22 5
2023/2024197 13 33 30 24 20 33 22 16 5 1 0 0
Totale 3.427